INDICATIONS FASENRA is indicated for: the add-on maintenance treatment of patients with severe asthma aged 6 years and older and with an eosinophilic phenotype. FASENRA is not indicated for the relief of acute bronchospasm or status asthmaticus ...
Mepolizumab US prescribing information. Available from:https://www.fda.gov/files/drugs/published/125526-Mepolizumab-Clinical-PREA.pdf[Last accessed:September 2024]. AstraZeneca plc. MANDARA Phase III data published inNew England Journal of Medicineshow remission is an achievable goal in eosinophilic gra...
‡Dosing comparison does not imply comparable efficacy, safety, or FDA-approved indications. IMPORTANT SAFETY INFORMATION Do not use FASENRAif you are allergic to benralizumab or any of the ingredients in FASENRA. Do not use to treat sudden breathing problems. ...